A theory for sleep, that also supports a restorative function for sleep, was proposed in which sleep functions essentially as an antioxidant for the brain where excess free radicals are removed during sleep (Reimund 1994)

Chapters: 00:00 The biggest mistake bodybuilders make 04:26 Jon Hecks football, strength, and nutrition background 08:00 Why bodybuilding training took over gen pop fitness 10:29 What bodybuilders are missing in the weight room 16:18 How to structure hybrid training without doing everything at once 21:50 Zone 2, intervals, and cardio for physique athletes 27:20 Conditioning, mitochondria, fat loss, and recovery 30:49 Loaded core training and why abs should be trained heavy 37:23 Calories in, calories out, and biological adaptation 43:47 Fiber, digestion, microbiome, and 10-minute walks 47:23 Performance nutrition vs physique nutrition 51:52 Training partners, PEDs, and electrolytes for intensity 59:30 Retatrutide, cognition, yohimbine, and fat loss compounds 01:05:13 DNP caution, SLU dosing, and mitochondrial peptides 01:12:23 What AI is doing to the coaching industry 01:16:57 Where to find Jon Heck Key Takeaways: Why many physique athletes need a rebuild phase before another fat loss push The training qualities bodybuilders ignore until they become obvious weak links How to think about hybrid training without turning every week into chaos Why Zone 2 and steps are useful, but not the whole cardio conversation The loaded core training conversation most bodybuilders avoid Why macro tracking is only one layer of the nutrition equation The electrolyte problem that may be limiting enhanced athletes in the gym A better way to think about retatrutide, yohimbine, SLU, and fat loss drugs The coaching skill AI still cannot replace Connect with Jon Heck: Website: Instagram: @whattheheck71 Podcast: Hammer and Chisel Performance Podcast The Guy Who Makes The IFBB Pros' Peptides: Why I Tell Clients to Take LESS Join the DDT Method Skool community Work with Drew Mike Metzger "The Fit Executive" is the founder of APR Health Solutions (Advanced Peptide Research), with 21 years of pharmaceutical, research-chemical, and CPG manufacturing experience

What should I do if I feel unwell while combining these methods
While oral GLP-1s dont solve all of these barriers, they do provide an option for my patients who refused to try injections
Lilly's NEJM-published phase 2 study showed: 17.5% mean weight reduction at 24 weeks with the highest dose 24.2% mean weight reduction at 48 weeks with the highest dose Dose-dependent improvement in glycemic markers GI side effects that were common but usually manageable That was the moment the molecule stopped looking like a clever concept and started looking like a serious obesity drug candidate